Literature DB >> 268450

[Clinical significance of cationic proteins of leukocyte lysosomes: cationic leukocyte antigen (CLA) as a marker of blast crisis in chronic myelocytic leukaemia (author's transl)].

F W Tischendorf, I Wüst, M M Tischendorf.   

Abstract

Cationic leukocyte antigen (CLA) was estimated in urine of acute and chronic leukaemics using quantitative immuno-precipitation techniques. The studies demonstrated that CLA is a marker of the (myelo-) blast crisis in patients with chronic myelocytic leukaemia (CML). By these studies the value of the determination of CLA for the differential diagnosis of acute myeloblastic leukaemia versus initial (myelo-) blast crisis in CML and the lymphatic leukaemias, respectively, was evident. The terminal blastic transformation in CML was indicated early by an elevation of the urinary CLA-level. The blast-crisis was accompanied by a heavy CLA-uria. The results are documented by demonstration of special studies of characteristic cases and discussed in the light of recent results of immunological and cytochemical findings on the nature of blast crisis in CML.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 268450     DOI: 10.1007/bf01478835

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  11 in total

1.  [Routine diagnostic determination of enzymes].

Authors:  H G KLEIN
Journal:  Wien Med Wochenschr       Date:  1959-02-28

2.  Serum lactic dehydrogenase and serum transaminase in human leukemia.

Authors:  G B MAGILL; F WROBLEWSKI; J S LADUE
Journal:  Blood       Date:  1959-07       Impact factor: 22.113

3.  [Behavior and origin of glycolytic serum enzyme in the human and its diagnostic significance].

Authors:  A ENGLHARDT-GOLKEL; R LOBEL; W SEITZ; I WOLLER
Journal:  Klin Wochenschr       Date:  1958-05-15

4.  Candidate leukaemia-specific antigen in man.

Authors:  G Brown; N Hogg; M Greaves
Journal:  Nature       Date:  1975-12-04       Impact factor: 49.962

5.  Heavy lysozymuria after X-irradiation of the spleen in human chronic myelocytic leukaemia.

Authors:  F W Tichendorf; G Ledderose; D Müller; W Wilmanns
Journal:  Nature       Date:  1972-02-04       Impact factor: 49.962

6.  [Urinary lysozyme activity in chronic myelocytic leukemia following x-ray treatment of the spleen].

Authors:  F W Tischendorf; G Ledderose; D Müller; D Orywall; W Wilmanns
Journal:  Klin Wochenschr       Date:  1972-03-01

7.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

8.  Heterogeneity of morphological, cytochemical, and cytogenetic features in the blastic phase of chronic granulocytic leukemia.

Authors:  M T Shaw; R H Bottomley; P N Grozea; R E Nordquist
Journal:  Cancer       Date:  1975-01       Impact factor: 6.860

9.  Cationic leukocyte antigen in urine of patients with chronic myelocytic leukaemia.

Authors:  F W Tischendorf; G Ledderose; W Wilmanns; M M Tischendorf; G W Tischendorf
Journal:  Nature       Date:  1973-10-19       Impact factor: 49.962

10.  Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia.

Authors:  E F Osserman; D P Lawlor
Journal:  J Exp Med       Date:  1966-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.